Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 107

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 107
---
 2 |     |        | 21,554,704 |     | $      | 2,157 |     |                    | 29,338 |     | $      | 3 |     | $          | 15,455,134 |   |     | $             | (204,847 | ) |     | $           | (20,932,504 | ) |     | $     | (5,679,043 | ) |
| Balance                                     |     |                    |     | 10,123,771 |     | $      | 1,011 |     |                     | 34 |     |        | - |     |                     | 15,007 |     | $      | 2 |     |        | 21,554,704 |     | $      | 2,157 |     |                    | 29,338 |     | $      | 3 |     | $          | 15,455,134 |   |     | $             | (204,847 | ) |     | $           | (20,932,504 | ) |     | $     | (5,679,043 | ) |

<div align='center'>The Accompanying Notes are an Integral Part of These Financial Statements

All stock amounts have been retroactively adjusted to reflect a 1 for 1500 reverse stock split of all issued series of stock effective as of March 6, 2023</div>

| 87 |

<div align='center'>REGEN BIOPHARMA , INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</div>

|                                                                                  |     | Quarter Ended     
 December 31, 2024 |          |   |     | Quarter Ended     
 December 31, 2023 |          |   |
|:---------------------------------------------------------------------------------|:----|:------------------|---------:|:--|:----|:------------------|---------:|:--|
|                                                                                  |     | -unaudited        |          |   |     | -unaudited        |          |   |
| CASH FLOWS FROM OPERATING ACTIVITIES                                             |     |                   |          |   |     |                   |          |   |
| Net Income (loss)                                                                |     | $                 | (515,384 | ) |     | $                 | (144,913 | ) |
| Adjustments to reconcile net Income to net cash                                  |     |                   |